Brainstorm Cell Therapeutics, Inc. (BCLI)

0.87 -0.03 (-3.33%) USD  |  OTCM  |  Sep 21, 16:00
More

Brainstorm Cell Therapeutics Price to CFO Per Share (TTM)

Price to CFO Per Share (TTM) Chart

View Price to CFO Per Share (TTM) for BCLI.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Price to CFO Per Share (TTM) Chart
Start Trial

Historical Price to CFO Per Share (TTM) Data

View and export this data back to . Start Trial.
Date Value
September 21, 2026 --

Price to CFO Per Share (TTM) Range, Past 5 Years

View Price to CFO Per Share (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Price to CFO Per Share (TTM) Benchmarks

View Price to CFO Per Share (TTM) Benchmarks
Start Trial
NovelStem International Corp. --
Summit Therapeutics, Inc. --
Kezar Life Sciences, Inc. --
Protara Therapeutics, Inc. --
Clene, Inc. --